259 related articles for article (PubMed ID: 33257647)
21. Dichloroacetate (DCA) enhances tumor cell death in combination with oncolytic adenovirus armed with MDA-7/IL-24.
Xiao L; Li X; Niu N; Qian J; Xie G; Wang Y
Mol Cell Biochem; 2010 Jul; 340(1-2):31-40. PubMed ID: 20165905
[TBL] [Abstract][Full Text] [Related]
22. Intratumor injection of oncolytic adenovirus expressing HSP70 prolonged survival in melanoma B16 bearing mice by enhanced immune response.
Ren Z; Ye X; Fang C; Lu Q; Zhao Y; Liu F; Liang M; Hu F; Chen HZ
Cancer Biol Ther; 2008 Feb; 7(2):191-95. PubMed ID: 18073525
[TBL] [Abstract][Full Text] [Related]
23. Combination of ZD55-MnSOD therapy with 5-FU enhances antitumor efficacy in colorectal cancer.
Zhang Y; Qin X; Zhang Y; Zhao L; Wang Y; Liu X; Yao L
J Cancer Res Clin Oncol; 2008 Feb; 134(2):219-26. PubMed ID: 17632733
[TBL] [Abstract][Full Text] [Related]
24. An oncolytic adenovirus that expresses the HAb18 and interleukin 24 genes exhibits enhanced antitumor activity in hepatocellular carcinoma cells.
Yuan S; Fang X; Xu Y; Ni A; Liu XY; Chu L
Oncotarget; 2016 Sep; 7(37):60491-60502. PubMed ID: 27528029
[TBL] [Abstract][Full Text] [Related]
25. Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1.
Zhang Z; Zou W; Wang J; Gu J; Dang Y; Li B; Zhao L; Qian C; Qian Q; Liu X
Mol Ther; 2005 Apr; 11(4):553-62. PubMed ID: 15771958
[TBL] [Abstract][Full Text] [Related]
26. An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice.
Pei Z; Chu L; Zou W; Zhang Z; Qiu S; Qi R; Gu J; Qian C; Liu X
Hepatology; 2004 May; 39(5):1371-81. PubMed ID: 15122766
[TBL] [Abstract][Full Text] [Related]
27. An armed oncolytic adenovirus system, ZD55-gene, demonstrating potent antitumoral efficacy.
Zhang ZL; Zou WG; Luo CX; Li BH; Wang JH; Sun LY; Qian QJ; Liu XY
Cell Res; 2003 Dec; 13(6):481-9. PubMed ID: 14728805
[TBL] [Abstract][Full Text] [Related]
28. Enhanced anti-tumor activity by the combination of a conditionally replicating adenovirus mediated interleukin-24 and dacarbazine against melanoma cells via induction of apoptosis.
Jiang G; Liu YQ; Wei ZP; Pei DS; Mao LJ; Zheng JN
Cancer Lett; 2010 Aug; 294(2):220-8. PubMed ID: 20189296
[TBL] [Abstract][Full Text] [Related]
29. Targeting gene-virotherapy of cancer and its prosperity.
Liu XY
Cell Res; 2006 Nov; 16(11):879-86. PubMed ID: 17102812
[TBL] [Abstract][Full Text] [Related]
30. Combination of Targeting Gene-ViroTherapy with 5-FU enhances antitumor efficacy in malignant colorectal carcinoma.
Qiu S; Ruan H; Pei Z; Hu B; Lan P; Wang J; Zhang Z; Gu J; Sun L; Qian C; Liu X; Qi Y
J Interferon Cytokine Res; 2004 Apr; 24(4):219-30. PubMed ID: 15144568
[TBL] [Abstract][Full Text] [Related]
31. Enhanced in-vitro and in-vivo suppression of A375 melanoma by combined IL-24/OSM adenoviral-mediated gene therapy.
Xu Y; Zhang F; Qin L; Miao J; Sheng W; Xie Y; Xu X; Yang J; Qian H
Melanoma Res; 2014 Feb; 24(1):20-31. PubMed ID: 24300090
[TBL] [Abstract][Full Text] [Related]
32. Oncolytic Adenovirus Complexes Coated with Lipids and Calcium Phosphate for Cancer Gene Therapy.
Chen J; Gao P; Yuan S; Li R; Ni A; Chu L; Ding L; Sun Y; Liu XY; Duan Y
ACS Nano; 2016 Dec; 10(12):11548-11560. PubMed ID: 27977128
[TBL] [Abstract][Full Text] [Related]
33. Targeting lung cancer stem-like cells with TRAIL gene armed oncolytic adenovirus.
Yang Y; Xu H; Huang W; Ding M; Xiao J; Yang D; Li H; Liu XY; Chu L
J Cell Mol Med; 2015 May; 19(5):915-23. PubMed ID: 25683371
[TBL] [Abstract][Full Text] [Related]
34. Oncolytic adenovirus-mediated intratumoral expression of TRAIL and CD40L enhances immunotherapy by modulating the tumor microenvironment in immunocompetent mouse models.
Liu W; Wang X; Feng X; Yu J; Liu X; Jia X; Zhang H; Wu H; Wang C; Wu J; Yu B; Yu X
Cancer Lett; 2022 Jun; 535():215661. PubMed ID: 35325845
[TBL] [Abstract][Full Text] [Related]
35. Targeting gene-virotherapy of cancer.
Liu XY; Gu JF
Cell Res; 2006 Jan; 16(1):25-30. PubMed ID: 16467873
[TBL] [Abstract][Full Text] [Related]
36. Potent antitumor efficacy of XAF1 delivered by conditionally replicative adenovirus vector via caspase-independent apoptosis.
Qi R; Gu J; Zhang Z; Yang K; Li B; Fan J; Wang C; He Z; Qiao L; Lin Z; Liu XY
Cancer Gene Ther; 2007 Jan; 14(1):82-90. PubMed ID: 17008933
[TBL] [Abstract][Full Text] [Related]
37. Antitumor effects of oncolytic adenovirus armed with Drosophila melanogaster deoxyribonucleoside kinase in colorectal cancer.
Ma S; Qu W; Mao L; Zhu Z; Jia L; Zhao L; Zheng X
Oncol Rep; 2012 May; 27(5):1443-50. PubMed ID: 22294034
[TBL] [Abstract][Full Text] [Related]
38. VEGI-armed oncolytic adenovirus inhibits tumor neovascularization and directly induces mitochondria-mediated cancer cell apoptosis.
Xiao T; Fan JK; Huang HL; Gu JF; Li LY; Liu XY
Cell Res; 2010 Mar; 20(3):367-78. PubMed ID: 19918267
[TBL] [Abstract][Full Text] [Related]
39. Enhanced antitumor activity by a selective conditionally replicating adenovirus combining with MDA-7/interleukin-24 for B-lymphoblastic leukemia via induction of apoptosis.
Qian W; Liu J; Tong Y; Yan S; Yang C; Yang M; Liu X
Leukemia; 2008 Feb; 22(2):361-9. PubMed ID: 18046450
[TBL] [Abstract][Full Text] [Related]
40. Complete elimination of colorectal tumor xenograft by combined manganese superoxide dismutase with tumor necrosis factor-related apoptosis-inducing ligand gene virotherapy.
Zhang Y; Gu J; Zhao L; He L; Qian W; Wang J; Wang Y; Qian Q; Qian C; Wu J; Liu XY
Cancer Res; 2006 Apr; 66(8):4291-8. PubMed ID: 16618754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
